Page last updated: 2024-10-30

methazolamide and Epilepsy

methazolamide has been researched along with Epilepsy in 1 studies

Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BASTIE, J1
GALLARDO-PONS, F1

Other Studies

1 other study available for methazolamide and Epilepsy

ArticleYear
[METHAZOLAMIDE TRIALS IN THE TREATMENT OF GENERALIZED EPILEPSY].
    Gazette medicale de France, 1963, Sep-10, Volume: 70

    Topics: Anticonvulsants; Epilepsy; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Methazolamide; Sul

1963